NovaQuest Capital Management, L.L.C.
Venture capitalRaleigh · Growth · 9 people tracked
Investment thesis
NovaQuest Capital Management invests in late-stage clinical and commercial-phase biopharmaceutical companies globally through private equity and related investment vehicles.
Team · 9 people
from the firm's websiteFrequently asked questions
- What stage does NovaQuest Capital Management, L.L.C. invest at?
- NovaQuest Capital Management, L.L.C. invests at the Growth stage.
- What sectors does NovaQuest Capital Management, L.L.C. focus on?
- NovaQuest Capital Management, L.L.C. focuses on Biotech, Enterprise Software, Healthtech, Medical Devices.
- Where is NovaQuest Capital Management, L.L.C. located?
- NovaQuest Capital Management, L.L.C. is headquartered in Raleigh, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Summit Partners is a growth-focused investment firm with over 41 years of experience investing in category-leading companies across technology, healthcare and life sciences, and growth products and services. The firm leverages a collaborative approach to support market leaders through both minority and majority investments.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.